risedronic acid (LKT Laboratories)
Structured Review

Risedronic Acid, supplied by LKT Laboratories, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/risedronic acid/product/LKT Laboratories
Average 91 stars, based on 1 article reviews
Images
1) Product Images from "Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma"
Article Title: Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
Journal: Investigational New Drugs
doi: 10.1007/s10637-020-01040-y
Figure Legend Snippet: Response of MPM and MeT-5A cell lines to fludarabine (F-araA) and risedronic acid (RIS) MPM- and MeT-5A cells (dotted red line) were treated with increasing concentrations (0.1 μM, 1 μM, 10 μM and 100 μM) of (A) F-araA and (B) RIS. Cell viability was measured after four days treatment using an ATP-based luminescence assay. Data represent mean ± SEM of three independent experiments, each performed in triplicate
Techniques Used: Luminescence Assay
Figure Legend Snippet: Proliferation of non-malignant line of mesotheliocytes, as LP-9 and HMC7, after treatment with fludarabine (F-araA) and risedronic acid (RIS) Proliferation rate was measured 24, 48 and 72 h after either vehicle (dotted lines) or drug treatment (this is day = 0), as F-araA at 1 μM (A, B) or RIS at 10 μM (C, D) . Data represent mean ± SEM of two independent experiments, each performed in duplicate
Techniques Used: